[Corrigendum] In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT‑116 xenograft model in nude mice
Author(s) -
Sitelbanat Yassin,
Jialiang Hu,
Hanmei Xu,
Ce Li,
Sarra Setrerrahmane
Publication year - 2020
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2020.7503
Subject(s) - in vivo , sunitinib , in vitro , cancer , oncogene , medicine , cancer research , oncology , medical physics , computer science , nuclear medicine , cell cycle , biology , genetics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom